Recent Publications about Screening
Related Resources
Back to NBL-PROF Home Page

Recent Publications

To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Morifuji M, et al. Fluorescent-based BAT-26 analysis for distinct screening of microsatellite instability in colorectal cancers. Int J Oncol 2003 Apr;22(4):807-13    [Related articles]

Krona C, et al. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 2003 Apr 17;22(15):2343-51    [Related articles]     Chromosome 1p

Honjo S, et al. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. Int J Cancer 2003 Feb 1;103(4):538-43    [Related articles]

Dobrovoljski G et al. False-positive results in neuroblastoma screening: the parents' view. J Pediatr Hematol Oncol 2003 Jan;25(1):14-8    [Related articles]

Pranzatelli MR, et al. Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatr Neurol 2002 Nov;27(5):384-7    [Related articles]

Suita S. Neuroblastoma screening in early life. N Engl J Med 2002 Sep 12;347(11):852-4; discussion 852-4    [Related articles]

Kerbl R, et al. Neuroblastoma screening in early life. N Engl J Med 2002 Sep 12;347(11):852-4; discussion 852-4    [Related articles]

Green NS. Neuroblastoma screening in early life. N Engl J Med 2002 Sep 12;347(11):852-4; discussion 852-4 [Letter]    [Related articles]

Collins MH. Neuroblastoma screening in early life. N Engl J Med 2002 Sep 12;347(11):852-4; discussion 852-4    [Related articles]

Burkhardt-Hammer T, et al. Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany. Med Pediatr Oncol 2002 Sep;39(3):156-62    [Related articles]

Behrends U, et al. Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library. Int J Cancer 2002 Aug 20;100(6):669-77    [Related articles]

Suita S. Mass screening for neuroblastoma in Japan: Lessons learned and future directions. J Pediatr Surg 2002 Jul;37(7):949-54    [Related articles]

Hase T, et al. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery? Pediatr Surg Int 2002 Jul;18(5-6):289-94    [Related articles]

Woods WG, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002 Apr 4;346(14):1041-6    [Related articles]

Tuffs A. Neuroblastoma screening does not reduce mortality. BMJ 2002 Apr 13;324(7342):867A    [Related articles]

Schilling FH, et al. Neuroblastoma screening at one year of age. N Engl J Med 2002 Apr 4;346(14):1047-53    [Related articles]

Yamamoto K, et al. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J Clin Oncol 2002 Mar 1;20(5):1209-14    [Related articles]

Nishi M, et al. Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality. J Exp Clin Cancer Res 2002 Mar;21(1):73-8    [Related articles]

Gripp KW, et al. Five additional Costello syndrome patients with rhabdomyosarcoma: Proposal for a tumor screening protocol. Am J Med Genet 2002 Feb 15;108(1):80-7    [Related articles]

Ohtori S, et al. Differential screening-selected gene aberrative in neuroblastoma protein modulates inflammatory pain in the spinal dorsal horn. Neuroscience 2002;110(3):579-86    [Related articles]

Morris JK. Screening for neuroblastoma in children. J Med Screen 2002;9(2):56    [Related articles]

Tajiri T, et al. Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan. Cancer 2001 Jul 15;92(2):349-53    [Related articles]

Hervas Benito I, et al. Screening value with 123 I-MIBG, neuronal specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma Rev Esp Med Nucl 2001 Jul;20(5):369-376    [Related articles]

Makimoto K, et al. Response bias by neuroblastoma screening participation status and social desirability bias in an anonymous postal survey, Ishikawa, Japan. J Epidemiol 2001 Mar;11(2):70-3    [Related articles]

Yoneda A, et al. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study. Med Pediatr Oncol 2001 Jan;36(1):160-2    [Related articles]

Brodeur GM, et al. Biological aspects of neuroblastomas identified by mass screening in Quebec. Med Pediatr Oncol 2001 Jan;36(1):157-9    [Related articles]

Schilling FH, et al. Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: Interim results. Med Pediatr Oncol 2000 Dec 1;35(6):701-704    [Related articles]

Parkin DM, et al. Lung cancer screening: improved survival but no reduction in deaths--the role of "overdiagnosis". Cancer 2000 Dec 1;89(11 Suppl):2369-76    [Related articles]

Ohira M, et al. Hunting the subset-specific genes of neuroblastoma: Expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries. Med Pediatr Oncol 2000 Dec 1;35(6):547-549    [Related articles]

Kawamoto T, et al. Association between favorable neuroblastoma and high expression of the novel metalloproteinase gene, nbla3145/XCE, cloned by differential screening of the full-length-enriched oligo-capping neuroblastoma cDNA l Med Pediatr Oncol 2000 Dec 1;35(6):628-631    [Related articles]

Furuta S, et al. Analysis of loss of heterozygosity at 16p12-p13 (familial neuroblastoma locus) in 470 neuroblastomas including both sporadic and mass screening tumors. Med Pediatr Oncol 2000 Dec 1;35(6):531-533    [Related articles]

Nishihira H, et al. Natural course of neuroblastoma detected by mass screening: A 5-year prospective study at a single institution. J Clin Oncol 2000 Aug;18(16):3012-7    [Related articles]

Ijiri R, et al. Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression. Am J Surg Pathol. 2000 Jun;24(6):807-15.    [Related articles]

Komuro H, et al. Laparoscopic resection of an adrenal neuroblastoma detected by mass screening that grew in size during the observation period. Surg Endosc. 2000; 14(3):297.    [Related articles]

Tsuchida Y, et al. Evaluation of the results of neuroblastoma screening at six months of age. [Letter] Med Pediatr Oncol. 2000 Jan;34(1):80-81.    [Related articles]

Parker L. The objective of cancer screening is to reduce disease-specific mortality, including screening for neuroblastoma. [Letter] Med Pediatr Oncol. 2000 Jan;34(1):82-83.    [Related articles]

Bozkowa K, et al. Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience. Med Wieku Rozwoj 1999 Oct-Dec;3(4):529-59 {Polish]    [Related articles]

[Conference Review] Report of the 1998 Consensus Conference on Neuroblastoma Screening. Med Pediatr Oncol. 1999 Oct;33(4):357-9.    [Related articles]

Philip T. Early detection of neuroblastoma in infants: Research? Yes. Routine Screening? No. Med Pediatr Oncol. 1999 Oct;33(4):355-6.    [Related articles]

Yokoyama S, et al. Neuroblastoma of the urinary bladder, preclinically detected by mass screening. Pediatrics. 1999 May;103(5):e67.    [Related articles]

Moe PJ. Screening for neuroblastoma and age-specific incidence. Acta Paediatr. 1999 Apr;88(4):362-4.    [Related articles]

Berthold F, et al. Which Cases Are Found and Missed by Neuroblastoma Screening at 1 Year? Results From the 1992 to 1995 Study in Three Federal States of Germany. J Clin Oncol. 1999;17(4):1200.    [Related articles]

Bessho F. Comparison of the incidences of neuroblastoma for screened and unscreened cohorts. Acta Paediatr. 1999 Apr;88(4):404-6.    [Related articles]

Ross JA, et al. Screening for neuroblastoma: progress and pitfalls. Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):189-94.    [Related articles]

Kaneko Y, et al. Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants. Int J Cancer. 1999 Jan 5;80(1):54-9.    [Related articles]     Chromosome 1p

Ijiri R, et al. Bladder origin neuroblastoma detected by mass screening. Urology. 1998 Dec;52(6):1139-41.    [Related articles]

Ajiki W, et al. Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Cancer Causes Control. 1998 Dec;9(6):631-6.    [Related articles]

Suita S, et al. Mass screening for neuroblastoma at 6 months of age: difficult to justify. J Pediatr Surg. 1998 Nov;33(11):1674-8.    [Related articles]

Nishi M, et al. Mass screening for neuroblastoma by HPLC and by non-HPLC: a review. Oncol Rep. 1998 Nov-Dec;5(6):1399-402. Review.    [Related articles]

Kerbl R, et al. Neuroblastoma screening in the United States: results of the Texas Outreach Program for Neuroblastoma Screening. Cancer. 1998 Nov 1;83(9):2047-8.    [Related articles]

Woods WG, et al. Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children. Eur J Cancer. 1997 Oct;33(12):2106-12.    [Related articles]

Tanaka T, et al. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening. Cancer. 1998 Oct 15;83(8):1626-33.    [Related articles]

Kudo K, et al. Japanese mass screening for neuroblastoma. Lancet. 1998 Oct 17;352(9136):1316.    [Related articles]

Taga T, et al. An infant with neuroblastoma and MYCN amplification found through mass screening. J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):486-8.    [Related articles]     MYCN Amplification

Powell JE, et al. Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe. Lancet. 1998 Aug 29;352(9129):682-7.    [Related articles]

Kerbl R, et al. Neuroblastoma screening for children: delay, repeat, or delete? Med Pediatr Oncol 1998 Aug;31(2):111-112    [Related articles]

Kawakami T, et al. Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project. Cancer 1998 Aug 1;83(3):575-581    [Related articles]

Erttmann R, et al. 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE). Eur J Cancer. 1998 Aug;34(9):1391-7.    [Related articles]

Bessho F Is there a future for neuroblastoma mass screening? Med Pediatr Oncol 1998 Aug;31(2):106-110    [Related articles]

Campion P, et al. Compliance in a screening program for neuroblastoma. Prev Med 1998 Jul;27(4):590-596    [Related articles]

Nishi M, et al. Mass screening for neuroblastoma targeting children age 14 months in Sapporo City: a preliminary report. Cancer. 1998 May 15;82(10):1973-7.    [Related articles]

Yamamoto K, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol. 1998 Apr;16(4):1265-9.    [Related articles]

Yamamoto K; Hayashi Y; Tanimura M; Shimanuki Y Moritani T; Oguma E; Aihara T; Ichikawa M; Kikuchi A; Hanada R Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 1998 Apr;16(4):1265-9

Matsumura T, et al. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line. Cancer. 1998 Apr 1;82(7):1416-8.    [Related articles]

Ater JL, et al. Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening. Cancer. 1998 Apr 15;82(8):1593-602.    [Related articles]

Mathieu P, et al. Screening infants for neuroblastoma: discovery of alkaptonuria in one case. Clin Chim Acta. 1997 Aug 29;264(2):255-9.    [Related articles]

Sasco AJ. [Screening for cancer: what's new]? Bull Cancer. 2000 Mar;87(3):239-43. Review. French.    [Related articles]

Hiraiwa H, et al. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line. Cancer. 1997 May 15;79(10):2036-44.    [Related articles]

Fukushi M, et al. International cooperation in neonatal screening: technical training course for newborn and infant screening. Southeast Asian J Trop Med Public Health 1999;30 Suppl 2:43-4    [Related articles]

Billings KR, et al. Screening sinus CT scans in pediatric bone marrow transplant patients. Int J Pediatr Otorhinolaryngol. 2000 May 30;52(3):253-260.    [Related articles]

Related Resources

Search PUBMED for "Neuroblastoma Screening" (National Library of Medicine, USA)
PDQ Statement: Neuroblastoma Screening (National Cancer Institute, USA)
Web Resources about Neuroblastoma (Children's Cancer Web)
Web Resources about Cancer Screening (Guide to Internet Resources for Cancer)

Back to NBL-PROF Home Page